肿瘤化疗多药耐药研究新进展

被引:7
作者
徐志渊
李德锐
机构
[1] 汕头大学医学院附属肿瘤医院
关键词
肿瘤; 多药耐药; 药物疗法;
D O I
暂无
中图分类号
R730.5 [肿瘤治疗学];
学科分类号
摘要
肿瘤化疗失败的主要原因是多药耐药(MDR)的产生。肿瘤多药耐药的机制十分广泛,其中以ATP结合盒式结构超家族成员研究较多。文章重点综述目前研究较多的多药耐药机制,并对肿瘤耐药逆转进展作简要介绍。
引用
收藏
页码:382 / 385
页数:4
相关论文
共 5 条
[1]  
Comparison of Chemotherapy Response with P-Glycoprotein, Multidrug Resistance-Related Protein-1, and Lung Resistance-Related Protein Expression in Untreated Small Cell Lung Cancer[J] . J.-J. Yeh,N.-Y. Hsu,W.-H. Hsu,C.-H. Tsai,C.-C. Lin,J.-A. Liang.Lung . 2005 (3)
[2]   Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure [J].
Guo, BQ ;
Villeneuve, DJ ;
Hembruff, SL ;
Kirwan, AF ;
Blais, DE ;
Bonin, M ;
Parissenti, AM .
BREAST CANCER RESEARCH AND TREATMENT, 2004, 85 (01) :31-51
[3]   Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28) [J].
Giri, U ;
Terry, NHA ;
Kala, SV ;
Lieberman, MW ;
Story, MD .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 55 (06) :511-521
[4]  
Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance[J] . Liwu Fu,Yongju Liang,Liwen Deng,Yan Ding,Liming Chen,Yanli Ye,Xiaoping Yang,Qichao Pan.Cancer Chemotherapy and Pharmacology . 2004 (4)
[5]   Comparing the relationship of Taxol-based chemotherapy response with P-glycoprotein and lung resistance-related protein expression in non-small cell lung cancer [J].
Chiou, JF ;
Liang, JA ;
Hsu, WH ;
Wang, JJ ;
Ho, ST ;
Kao, A .
LUNG, 2003, 181 (05) :267-273